The global compact c-arm market was valued at $409.8 million in 2023, and is projected to reach $714.1 million by 2033, growing at a CAGR of 5.7% from 2024 to 2033.
The global implantable neurostimulation devices market was valued at $1.7 billion in 2023, and is projected to reach $4.3 billion by 2033, growing at a CAGR of 9.7% from 2024 to 2033.
The global chemotherapy induced peripheral neuropathy treatment market was valued at $0.9 billion in 2023, and is projected to reach $1.6 billion by 2033, growing at a CAGR of 6.1% from 2024 to 2033.
